Nisa Investment Advisors
KPTI icon

Nisa Investment Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Nisa Investment Advisors’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$43 – 3006
2024
Q2 		$43 Sell
3
-10
-77% -$166 ﹤0.01% 2908
2024
Q1 		$305 Buy
+13
New +$228 ﹤0.01% 2580
2023
Q4 		– Sell
-53
Closed -$1.07K – 2691
2023
Q3 		$1.07K Hold
53
– – ﹤0.01% 2388
2023
Q2 		$1.43K Sell
53
-4
-7% -$172 ﹤0.01% 2389
2023
Q1 		$3K Buy
57
+4
+8% +$197 ﹤0.01% 2286
2022
Q4 		$3K Sell
53
-327
-86% -$22.7K ﹤0.01% 2340
2022
Q3 		$26K Buy
380
+327
+617% +$24.4K ﹤0.01% 1979
2022
Q2 		$4K Hold
53
– – ﹤0.01% 2297
2022
Q1 		$6K Hold
53
– – ﹤0.01% 2287
2021
Q4 		$7K Hold
53
– – ﹤0.01% 2068
2021
Q3 		$5 Hold
53
– – ﹤0.01% 2257
2021
Q2 		$8 Sell
53
-217
-80% -$31.5K ﹤0.01% 2248
2021
Q1 		$43 Hold
270
– – ﹤0.01% 2008
2020
Q4 		$63K Buy
270
+37
+16% +$8.57K ﹤0.01% 1921
2020
Q3 		$51K Buy
233
+176
+309% +$43K ﹤0.01% 1798
2020
Q2 		$16K Buy
57
+18
+46% +$5.32K ﹤0.01% 1825
2020
Q1 		$11K Buy
+39
New +$10.8K ﹤0.01% 1836

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Nisa Investment Advisors's KPTI Position: Q3 2024 in Review

Nisa Investment Advisors sold out of Karyopharm Therapeutics (KPTI) in Q3 2024, closing a stake of 3 shares — an estimated $43 sold.

Nisa Investment Advisors first reported a position in KPTI in Q1 2020 and held it in 17 quarters. The position peaked at $63K in Q4 2020. 91 funds tracked by Wall St. Rank hold KPTI as of Q3 2024.

  • Nisa Investment Advisors reported no remaining Karyopharm Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 3 Karyopharm Therapeutics shares in Q3 2024, an estimated $43.
  • Nisa Investment Advisors first reported a position in Karyopharm Therapeutics in Q1 2020 and held it in 17 quarters.
  • Nisa Investment Advisors's Karyopharm Therapeutics position peaked at $63K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2024.

Based on Nisa Investment Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.